 Rebecca Hanratty
Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension | 7 | 2022 | 1063 | 0.820 |
Why?
| | Kidney Diseases | 2 | 2011 | 355 | 0.570 |
Why?
| | Patient Discharge | 2 | 2020 | 769 | 0.550 |
Why?
| | Analgesics, Opioid | 3 | 2022 | 785 | 0.500 |
Why?
| | Safety-net Providers | 3 | 2021 | 95 | 0.490 |
Why?
| | Pharmacy Service, Hospital | 1 | 2013 | 84 | 0.410 |
Why?
| | Specialization | 1 | 2013 | 117 | 0.410 |
Why?
| | Telemedicine | 1 | 2020 | 666 | 0.410 |
Why?
| | Antihypertensive Agents | 4 | 2021 | 430 | 0.390 |
Why?
| | Medically Underserved Area | 2 | 2010 | 80 | 0.390 |
Why?
| | Patient-Centered Care | 2 | 2013 | 475 | 0.380 |
Why?
| | Continuity of Patient Care | 1 | 2013 | 254 | 0.370 |
Why?
| | Community Health Workers | 1 | 2010 | 46 | 0.360 |
Why?
| | Racism | 3 | 2021 | 101 | 0.360 |
Why?
| | Blood Pressure | 3 | 2014 | 1536 | 0.340 |
Why?
| | Medication Adherence | 5 | 2022 | 536 | 0.340 |
Why?
| | Social Values | 2 | 2021 | 36 | 0.300 |
Why?
| | Medical Records Systems, Computerized | 1 | 2008 | 91 | 0.300 |
Why?
| | Colorado | 11 | 2022 | 4120 | 0.280 |
Why?
| | Community Health Services | 1 | 2008 | 212 | 0.270 |
Why?
| | Kidney | 2 | 2011 | 1208 | 0.270 |
Why?
| | Registries | 4 | 2012 | 1773 | 0.270 |
Why?
| | Opioid-Related Disorders | 2 | 2022 | 423 | 0.250 |
Why?
| | Health Promotion | 1 | 2010 | 690 | 0.240 |
Why?
| | Risk Assessment | 5 | 2021 | 3004 | 0.230 |
Why?
| | Patient Readmission | 2 | 2021 | 607 | 0.210 |
Why?
| | Middle Aged | 17 | 2022 | 27063 | 0.210 |
Why?
| | Retrospective Studies | 9 | 2022 | 12609 | 0.200 |
Why?
| | Cardiovascular Diseases | 2 | 2010 | 1724 | 0.200 |
Why?
| | Hospitalization | 2 | 2023 | 1758 | 0.200 |
Why?
| | Pharmacies | 1 | 2022 | 33 | 0.200 |
Why?
| | Epidemics | 1 | 2022 | 70 | 0.200 |
Why?
| | Algorithms | 1 | 2008 | 1492 | 0.190 |
Why?
| | Aged | 11 | 2021 | 19282 | 0.190 |
Why?
| | Prescriptions | 1 | 2020 | 59 | 0.180 |
Why?
| | Physician-Patient Relations | 3 | 2013 | 466 | 0.180 |
Why?
| | Inpatients | 1 | 2023 | 378 | 0.170 |
Why?
| | Buprenorphine | 1 | 2022 | 138 | 0.170 |
Why?
| | Patient Satisfaction | 2 | 2013 | 585 | 0.160 |
Why?
| | Adult | 13 | 2022 | 30782 | 0.160 |
Why?
| | Humans | 23 | 2023 | 115841 | 0.160 |
Why?
| | Attitude to Health | 1 | 2021 | 410 | 0.150 |
Why?
| | Hypertrophy, Left Ventricular | 2 | 2008 | 103 | 0.150 |
Why?
| | Medical Overuse | 1 | 2018 | 31 | 0.150 |
Why?
| | Drug Overdose | 1 | 2022 | 295 | 0.150 |
Why?
| | Glomerular Filtration Rate | 2 | 2011 | 605 | 0.150 |
Why?
| | Hospitals, Urban | 1 | 2018 | 129 | 0.150 |
Why?
| | Male | 17 | 2022 | 56101 | 0.140 |
Why?
| | Ambulatory Care | 1 | 2020 | 480 | 0.140 |
Why?
| | Female | 17 | 2022 | 60045 | 0.140 |
Why?
| | Models, Statistical | 2 | 2018 | 616 | 0.140 |
Why?
| | Hospitals | 1 | 2020 | 582 | 0.130 |
Why?
| | Incidence | 3 | 2011 | 2333 | 0.130 |
Why?
| | Risk Factors | 6 | 2021 | 8714 | 0.130 |
Why?
| | Primary Health Care | 3 | 2014 | 1517 | 0.120 |
Why?
| | Electrocardiography | 3 | 2020 | 551 | 0.120 |
Why?
| | Chi-Square Distribution | 2 | 2012 | 502 | 0.110 |
Why?
| | Myocardial Infarction | 1 | 2020 | 931 | 0.110 |
Why?
| | Blood Pressure Determination | 1 | 2014 | 123 | 0.110 |
Why?
| | Follow-Up Studies | 3 | 2022 | 4445 | 0.100 |
Why?
| | Pandemics | 1 | 2020 | 1332 | 0.100 |
Why?
| | Telephone | 1 | 2013 | 153 | 0.100 |
Why?
| | Time Factors | 3 | 2012 | 6186 | 0.100 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1177 | 0.100 |
Why?
| | Professional Role | 1 | 2013 | 151 | 0.100 |
Why?
| | Hyperlipidemias | 1 | 2012 | 123 | 0.100 |
Why?
| | Proportional Hazards Models | 2 | 2011 | 1088 | 0.090 |
Why?
| | Anticholesteremic Agents | 1 | 2012 | 129 | 0.090 |
Why?
| | Community-Institutional Relations | 1 | 2010 | 89 | 0.090 |
Why?
| | Physicians, Primary Care | 1 | 2013 | 222 | 0.090 |
Why?
| | Linear Models | 1 | 2011 | 778 | 0.080 |
Why?
| | Risk Reduction Behavior | 1 | 2010 | 196 | 0.080 |
Why?
| | Minority Groups | 1 | 2010 | 232 | 0.080 |
Why?
| | Length of Stay | 1 | 2013 | 963 | 0.080 |
Why?
| | Life Style | 1 | 2010 | 428 | 0.080 |
Why?
| | Risk | 1 | 2010 | 830 | 0.080 |
Why?
| | Diabetes Complications | 1 | 2009 | 212 | 0.080 |
Why?
| | Socioeconomic Factors | 2 | 2009 | 1090 | 0.070 |
Why?
| | Comorbidity | 2 | 2012 | 1476 | 0.070 |
Why?
| | Young Adult | 4 | 2021 | 10501 | 0.070 |
Why?
| | Aged, 80 and over | 2 | 2021 | 6433 | 0.070 |
Why?
| | Drug Prescriptions | 1 | 2009 | 241 | 0.070 |
Why?
| | Healthcare Disparities | 3 | 2021 | 486 | 0.070 |
Why?
| | Communication | 1 | 2012 | 749 | 0.070 |
Why?
| | Vascular Diseases | 1 | 2009 | 230 | 0.070 |
Why?
| | Urban Health Services | 2 | 2021 | 61 | 0.070 |
Why?
| | Logistic Models | 3 | 2021 | 1865 | 0.070 |
Why?
| | Patient Education as Topic | 1 | 2010 | 686 | 0.070 |
Why?
| | United States | 4 | 2022 | 12336 | 0.060 |
Why?
| | Attitude of Health Personnel | 1 | 2012 | 990 | 0.060 |
Why?
| | Delivery of Health Care | 1 | 2012 | 847 | 0.060 |
Why?
| | Odds Ratio | 2 | 2021 | 970 | 0.060 |
Why?
| | Hypoglycemic Agents | 1 | 2012 | 1006 | 0.060 |
Why?
| | Survival Analysis | 1 | 2008 | 1221 | 0.060 |
Why?
| | Disease Progression | 1 | 2011 | 2424 | 0.060 |
Why?
| | Diabetes Mellitus | 1 | 2012 | 905 | 0.060 |
Why?
| | Chronic Disease | 1 | 2009 | 1602 | 0.060 |
Why?
| | Mass Screening | 1 | 2010 | 1023 | 0.060 |
Why?
| | Prognosis | 1 | 2011 | 3341 | 0.060 |
Why?
| | Cohort Studies | 2 | 2009 | 4960 | 0.050 |
Why?
| | Intention to Treat Analysis | 1 | 2021 | 69 | 0.050 |
Why?
| | Opiate Substitution Treatment | 1 | 2022 | 102 | 0.050 |
Why?
| | Naloxone | 1 | 2022 | 98 | 0.050 |
Why?
| | Single-Blind Method | 1 | 2021 | 256 | 0.050 |
Why?
| | Health Maintenance Organizations | 2 | 2012 | 96 | 0.050 |
Why?
| | Health Care Surveys | 2 | 2013 | 540 | 0.050 |
Why?
| | Adolescent | 3 | 2013 | 17943 | 0.050 |
Why?
| | Chest Pain | 1 | 2020 | 82 | 0.050 |
Why?
| | Writing | 1 | 2021 | 85 | 0.050 |
Why?
| | Professional-Patient Relations | 1 | 2021 | 143 | 0.050 |
Why?
| | Narcotic Antagonists | 1 | 2022 | 138 | 0.050 |
Why?
| | Mental Disorders | 1 | 2008 | 908 | 0.040 |
Why?
| | Substance-Related Disorders | 1 | 2008 | 953 | 0.040 |
Why?
| | Health Status Disparities | 1 | 2021 | 208 | 0.040 |
Why?
| | Pharmacists | 1 | 2022 | 235 | 0.040 |
Why?
| | Referral and Consultation | 1 | 2023 | 646 | 0.040 |
Why?
| | Self Report | 1 | 2022 | 701 | 0.040 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2021 | 1192 | 0.030 |
Why?
| | Stereotyped Behavior | 1 | 2012 | 19 | 0.030 |
Why?
| | Cultural Competency | 1 | 2013 | 73 | 0.030 |
Why?
| | Trust | 1 | 2012 | 108 | 0.020 |
Why?
| | Cholesterol, LDL | 1 | 2012 | 309 | 0.020 |
Why?
| | Affect | 1 | 2012 | 244 | 0.020 |
Why?
| | Emergency Service, Hospital | 1 | 2020 | 1840 | 0.020 |
Why?
| | Pilot Projects | 1 | 2014 | 1374 | 0.020 |
Why?
| | Prevalence | 1 | 2014 | 2269 | 0.020 |
Why?
| | Nutrition Surveys | 1 | 2008 | 225 | 0.020 |
Why?
| | Statistics as Topic | 1 | 2008 | 299 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2009 | 1444 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2009 | 1817 | 0.010 |
Why?
| | Survival Rate | 1 | 2008 | 1652 | 0.010 |
Why?
| | Biomarkers | 1 | 2012 | 3473 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2012 | 9164 | 0.010 |
Why?
|
|
Hanratty's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|